Unilens Vision Inc.'s Board of Directors declared its regular quarterly cash dividend of $0.09 per common share, payable on November 27, 2009 to stockholders of record at the close of business on November 13, 2009.

Unilens Vision Inc. announced the launch of the all new monthly C-VUE Advanced®Toric Multifocal. The C-VUE Advanced Toric Multifocal for astigmatic presbyopes will be sold directly to independent eye care professionals offering technology so sophisticated, it will allow for complete customization including the capability to specify the ADD power and zone size. The monthly replacement lens features a free trial program, advanced hydration material and exceptional deliverability (typically ships within 2 to 3 days). C-VUE Advanced Toric Multifocal is available in new convenient blister packaging with hioxifilcon D, a material which offers advanced hydration properties that allow it to retain 97% of its moisture resulting in all day comfort. As the presbyopic population continues to grow faster than the population as a whole, this new product offering (for astigmatic presbyopes) and free trial program will provide independent practitioners with an additional specialty C-VUE contact lens option that contributes to patient retention and practice profitability. C-VUE Advanced Toric Multifocal is an easy to fit specialty toric multifocal contact lens, designed in an extremely wide range of customizable parameters with exceptional deliverability. The lens offers made to order base curves, diameters, powers and cylinders combined with axis in one degree steps. Practitioners can even specify individual ADD powers and zone sizes.

Unilens Vision Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2009. For the quarter, the company reported net sales excluding royalty income decreased 4.4% to $1,731,370 compared to $1,811,447 in the prior-year. Net sales of the Company's C-Vue brand disposable contact lenses increased approximately 7% during the fourth quarter of FY2009, while Low Vision stocking orders to exclusive distributor declined, along with the expected decline in replacement lens category. Income before taxes increased 4.0% to $880,954 compared with $846,701 in the prior-year. The company reported net income of $597,965 or $0.13 per diluted share. This compared with net income of $508,651 or $0.11 per diluted share in the prior-year fourth quarter, which included net income tax expense of $338,050. Income from operations was $150,316 compared to $101,684 for the same period of last year. Income before income tax expense was $880,954 compared to $846,701 for the same period of last year. Cash provided by operating activities was $945,249 compared to $845,756 for the same period of last year. For the full year, the company reported net sales, excluding royalty income, increased 0.9% to $6,724,181 compared with $6,665,566 in the previous fiscal year. The increase was primarily a result of continued growth of the Company's C-Vue brand disposable specialty contact lenses, sold exclusively to licensed eye care professionals. Income before taxes increased 13.8% to a record $3,001,179 compared with $2,636,652 in the prior-year. After recording net income tax expense of $1,131,052, the company reported net income of $1,870,127 or $0.41 per diluted share. In 2008, the company reported net income of $1,630,592 or $0.36 per diluted share, which included income tax expense of $1,006,060. Income from operations was $184,171 compared to $24,818 for the same period of last year. Income before income tax expense was $3,001,179 compared to $2,636,652 for the same period of last year. Cash provided by operating activities was $3,201,023 compared to $2,694,414 for the same period of last year.